about
Structure of Bradavidin – C-Terminal Residues Act as Intrinsic LigandsPre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinomaEvaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical useGalactosylated poly-L-lysine targeted microbubbles for ultrasound mediated antisense c-myc gene transfection in hepatocellular carcinoma cellsConstruction of chimeric dual-chain avidin by tandem fusion of the related avidins.Structure-Based Design of Reactive Nucleosides for Site-Specific Modification of the A2A Adenosine ReceptorThe potential and hurdles of targeted alpha therapy - clinical trials and beyond.Synthetic virology: engineering viruses for gene deliveryLayer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxiaA novel approach to make homogeneous protease-stable monovalent streptavidin.Single reporter for targeted multimodal in vivo imagingImproving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin SystemHigh Affinity Macrocycle Threading by a Near-Infrared Croconaine Dye with Flanking Polymer ChainsIsolation, cloning, and expression of E. coli BirA gene for biotinylation applicationsExpression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platformAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapyMacromolecules as taxane delivery systems.The use of reversible addition fragmentation chain transfer polymerization for drug delivery systems.The application of nanoparticles in gene therapy and magnetic resonance imaging.Retargeting of viruses to generate oncolytic agents.Streptavidin-biotin technology: improvements and innovations in chemical and biological applications.Synthesis of a new class of ribose functionalized dinucleotide cap analogues for biophysical studies on interaction of cap-binding proteins with the 5' end of mRNA.Synthetic mimics of biotin/(strept)avidin.Biotin-guided anticancer drug delivery with acidity-triggered drug release.New insights into the pretargeting approach to image and treat tumours.Development of streptavidin-based nanocomplex for siRNA delivery.Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.Direct biomolecule binding on nonfouling surfaces via newly discovered supramolecular self-assembly of lysozyme under physiological conditions.Pentafluorobenzene end-group as a versatile handle for para fluoro "click" functionalization of polythiophenes.Characterization of therapeutic protein AvidinOX by an integrated analytical approach.Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers.Enzyme-Responsive LipoCEST Agents: Assessment of MMP-2 Activity by Measuring the Intra-liposomal Water 1 H NMR Shift.Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer.Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System.Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.Conditional expression of Lodavin, an avidin-tagged LDL receptor, for biotin-mediated applications in vivo.Fluorescence enhancement of fluorescent unnatural streptavidin by binding of a biotin analogue with spacer tail and its application to biotin sensing.
P2860
Q27679001-1A1B4AA1-62F5-47B0-B04E-812EEBA60DB8Q28481572-F526ACD8-F88E-4A76-B152-4F84541C147FQ28652076-9632B287-2501-4AF0-B86B-D909FAD73B59Q30411283-90DD08A1-A2A7-493C-A8F7-E07FBE19ED40Q33927096-893CE587-1D9A-4051-B8DF-334AE46E2DBCQ34162656-F1ED191E-73B0-4E7A-9F27-809B911DD8F5Q34399879-6C408494-A952-4C1C-81D4-08FAC4F9B8C6Q34487264-C8446C93-2D2F-4445-B6F5-005422B2FB73Q35074580-E5646537-975E-4406-B0B6-C73A32249DBBQ35841372-C1F6483E-6AD5-4064-AAA8-06A039D468A8Q35848195-6D059E9E-3095-45E2-868A-4B1553768578Q35881624-3B949EAF-4FED-4583-81A7-D42916D5FFE3Q35903067-A8119AA1-45F6-481D-8762-6EDB17DBBBC7Q35999803-2E3B0F0C-0B46-4CBF-830A-959815F0114CQ36216709-46904F58-9EFA-478B-9D28-20C1CA4F0778Q36395999-6B4B6162-999E-4500-A016-ED41AE9C0C29Q36477594-7BA49E96-A0C1-47F6-947C-3DDCD09BD524Q36501550-C0F1E14F-92CF-40F2-B7E1-B03CBC33042AQ36534262-4798F961-07DB-4506-BDC7-496F4881D1ABQ37818236-50D21187-E5DE-4C35-A264-4A79505E840CQ37830703-38A502B2-5F9F-4A30-87DD-A715B069F309Q37864251-33C603DB-B75B-47FA-9A0B-14A7F55237FDQ37982062-B653DAE6-274E-4028-BB98-5FCF673396FFQ38140695-204E7A5E-FBAD-4723-8103-435DECC4239CQ38333995-8C0C388B-EA33-4F47-B341-ED4CE85F3E04Q38758309-865F27CE-FC21-4284-B0D5-FEBFB04CA325Q38877017-C9678680-A6B9-49E2-9F0C-C8E699F89430Q38976879-FF3C8AB7-7659-4418-9489-6B07B5E4541FQ39070514-D7650AF0-FA56-45AC-921F-59222B22061CQ41585067-6AABFF3E-F292-4641-92E3-4D0D52A65D3FQ42040627-B6E966E9-FDEB-4C54-8B00-E5310B257597Q42290259-2B8B1029-A9BE-44AC-AE5B-CD2C1DD4FDB9Q47371861-6CD2131C-036E-49E8-8B30-A80A11B932B5Q47403446-542F8D28-C889-47EC-8551-F747C476C709Q47955808-A5206DDF-68C7-409E-98DB-AC73FD29BC87Q48658092-22A87BEC-F00B-4CC8-A75E-ADFC04464076Q50009555-C4ACC555-2897-435F-9CDE-045E20BCBE2EQ50089571-B24A5740-7110-4922-A4A8-A6D2F7A68A42Q51797569-AE1D2803-99BE-4E54-B952-12FADA33AC9AQ53560887-AB8BA5DD-EE2A-4444-9591-E691DDC809C2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Avidin-biotin technology in targeted therapy.
@en
Avidin-biotin technology in targeted therapy.
@nl
type
label
Avidin-biotin technology in targeted therapy.
@en
Avidin-biotin technology in targeted therapy.
@nl
prefLabel
Avidin-biotin technology in targeted therapy.
@en
Avidin-biotin technology in targeted therapy.
@nl
P2860
P1476
Avidin-biotin technology in targeted therapy.
@en
P2093
Hanna P Lesch
Jere T Pikkarainen
P2860
P304
P356
10.1517/17425241003677749
P407
P577
2010-05-01T00:00:00Z